BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saponaro C, Scarpi E, Zito FA, Giotta F, Silvestris N, Mangia A. Independent Negative Prognostic Role of TCF1 Expression within the Wnt/β-Catenin Signaling Pathway in Primary Breast Cancer Patients. Cancers (Basel) 2019;11:E1035. [PMID: 31336689 DOI: 10.3390/cancers11071035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Porcelli L, Di Fonte R, Pierri CL, Fucci L, Saponaro C, Armenio A, Serratì S, Strippoli S, Fasano R, Volpicella M, Daprile R, Tommasi S, Ressa CM, Guida M, Azzariti A. BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy. Pharmacol Res 2022;182:106323. [PMID: 35752358 DOI: 10.1016/j.phrs.2022.106323] [Reference Citation Analysis]
2 Hafezi N, Alizadeh-Navaei R, Golpour M, Zafari P, Ajami A. Role of Frizzled receptor expression on patients' survival with gastrointestinal cancers: A systematic review with meta-analysis. Caspian J Intern Med 2022;13:1-9. [PMID: 35178201 DOI: 10.22088/cjim.13.1.1] [Reference Citation Analysis]
3 Raut D, Vora A, Bhatt LK. The Wnt/β-catenin pathway in breast cancer therapy: a pre-clinical perspective of its targeting for clinical translation. Expert Rev Anticancer Ther 2021;:1-18. [PMID: 34927527 DOI: 10.1080/14737140.2022.2016398] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Silvestris N, Argentiero A, Brunetti O, Sonnessa M, Colonna F, Delcuratolo S, Luchini C, Scarpa A, Lonardi S, Nappo F, Fassan M, Solimando AG, Fucci L, Saponaro C. PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study. Expert Opin Ther Targets 2021;:1-10. [PMID: 34846251 DOI: 10.1080/14728222.2021.2011859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Zhou X, Jiang J, Guo S. Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway. J Ovarian Res 2021;14:118. [PMID: 34507595 DOI: 10.1186/s13048-021-00859-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 You Z, He L, Yan N. Tunicamycin-Induced Endoplasmic Reticulum Stress Promotes Breast Cancer Cell MDA-MB-231 Apoptosis through Inhibiting Wnt/β-Catenin Signaling Pathway. J Healthc Eng 2021;2021:6394514. [PMID: 34336161 DOI: 10.1155/2021/6394514] [Reference Citation Analysis]
7 Tien TZ, Lee JNLW, Lim JCT, Chen XY, Thike AA, Tan PH, Yeong JPS. Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence. Histopathology 2021;79:139-59. [PMID: 33400265 DOI: 10.1111/his.14328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Sha YL, Liu S, Yan WW, Dong B. Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma. Biosci Rep 2019;39:BSR20192466. [PMID: 31511432 DOI: 10.1042/BSR20192466] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
9 Mangia A, Saponaro C, Vagheggini A, Opinto G, Centonze M, Vicenti C, Popescu O, Pastena M, Giotta F, Silvestris N. Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients? Cancers (Basel) 2019;11:E1393. [PMID: 31540486 DOI: 10.3390/cancers11091393] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]